Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 2.34 BRL -2.09% Market Closed
Market Cap: 1.5B BRL
Have any thoughts about
Oncoclinicas do Brasil Servicos Medicos SA?
Write Note
Section:
 

Relative Value

The Relative Value of one ONCO3 stock under the Base Case scenario is 19.18 BRL. Compared to the current market price of 2.34 BRL, Oncoclinicas do Brasil Servicos Medicos SA is Undervalued by 88%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ONCO3 Relative Value
Base Case
19.18 BRL
Undervaluation 88%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
95
vs Industry
72
Median 3Y
0.9
Median 5Y
0.9
Industry
2.3
Forward
0.2
More Details
20.5
P/E
P/E
Price to Earnings
20.5
vs History
26
vs Industry
27
Median 3Y
21.6
Median 5Y
21.1
Industry
23.2
Forward
8.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
4
Median 3Y
-10.6
Median 5Y
-10.7
Industry
14.3
More Details
1.8
P/FCFE
P/FCFE
Price to FCFE
1.8
vs History
43
vs Industry
Median 3Y
-10.3
Median 5Y
-5.1
Industry
20.1
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
92
vs Industry
44
Median 3Y
2
Median 5Y
1.9
Industry
2.2
More Details
0.7
EV/S
EV/S
Enterprise Value to Sales
0.7
vs History
95
vs Industry
59
Median 3Y
1.4
Median 5Y
1.4
Industry
2.4
Forward
0.6
More Details
2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2
vs History
95
vs Industry
50
Median 3Y
4.1
Median 5Y
4.1
Industry
5
More Details
4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4
vs History
95
vs Industry
39
Median 3Y
8.4
Median 5Y
8.5
Industry
12.8
Forward
3.3
More Details
5.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.5
vs History
92
vs Industry
36
Median 3Y
11.2
Median 5Y
11.2
Industry
17.2
Forward
4.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
2
Median 3Y
-17.3
Median 5Y
-17.5
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-10.7
Median 5Y
-11.5
Industry
18.2
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
95
vs Industry
60
Median 3Y
1
Median 5Y
1
Industry
1.9
More Details

Multiples Across Competitors

ONCO3 Competitors Multiples
Oncoclinicas do Brasil Servicos Medicos SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
1.5B BRL 0.2 20.5 4 5.5
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9

See Also

Summary
ONCO3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONCO3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONCO3 stock valuation using valuation multiples.
Wall Street Estimates
ONCO3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONCO3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.